WebMD Health News
Review by Michael W. Smith, MD
December 29, 2014-The FDA has approved a combination drug for moderate to severe Alzheimer’s disease in people who have already been treated with both drugs.
A pill called Namzaric is a combination of memantine hydrochloride sustained release (namenda) and donepezil hydrochloride (aricept).
The two drugs are often prescribed together. About 70% of Namenda XRs also use Aricept, Dr. David Nicholson said in a statement. He is Senior Vice President of Global Brand R & D for the pharmaceutical company Actavis.
“Both Namenda XR and donepezil have proven effective and safe in the treatment of moderate to severe Alzheimer’s disease,” says Nicholson. Studies also show that people who take combopills show a greater improvement overall and, when considered, than those who take donepezil alone, he says.
Namzaric is a capsule that is taken once a day. For those who are difficult to swallow, you can open the capsule and sprinkle on food. The drug will be available with two strengths.
Continue scrolling for the next news article
Source: Medscape: “FDA approves Alzheimer’s disease combo pill”
© 2014 WebMD, LLC. all rights reserved.
FDA approves Alzheimer’s disease combo pill
Source link FDA approves Alzheimer’s disease combo pill